CAPRICOR THERAPEUTICS, INC. (CAPR) Operating margin 2016–2024
CAPRICOR THERAPEUTICS, INC. (CAPR) operating margin by fiscal year — reported operating income divided by reported revenue.
-191.1%FY2024 · since FY2016: -424.6% → -191.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -191.1% | -95.5 pp |
| FY2023 | -95.6% | +1068.3 pp |
| FY2022 | -1163.9% | +7385.9 pp |
| FY2021 | -8549.9% | -4137.3 pp |
| FY2020 | -4412.6% | -3643.0 pp |
| FY2019 | -769.5% | +147.5 pp |
| FY2018 | -917.0% | -434.6 pp |
| FY2017 | -482.4% | -57.8 pp |
| FY2016 | -424.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice